SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Vivus, Why the Slide?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: hal jordan who wrote (3358)9/15/1997 10:35:00 AM
From: Tokyo VD   of 3991
 
Hal, watch out for Zonagen. The timeline for regulatory submission is later this year, which means first approval could come 9-12 months later (if at all in Zonagen's case). By the way, which firm does your broker work at? I've heard alot of New York stockbrokers pushing this one.

As for Vivus, I don't know what to make of it, but I just heard that there is some negative news forthcoming (possibly as early as later today). I sold my stock this morning and as the stock trades off at this time, it looks like I finally might have had some good timing. I'm going to let this "news" blow over (if it ever comes) and then hop back in.

Good luck to all.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext